Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

被引：2
|
作者：
Thenappan, Thenappan [1 ]
Weir, E. Kenneth [1 ]
Prins, Kurt W. [1 ]
Pritzker, Marc R. [1 ]
Archer, Stephen L. [2 ]
机构：
[1] Univ Minnesota, Sch Med, Cardiovasc Div, Minneapolis, MN 55455 USA
[2] Queens Univ Kingston, Dept Med, Kingston, ON, Canada
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 14期
基金：
加拿大创新基金会;
关键词：
D O I：
10.1161/JAHA.121.021518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Prisco, Sasha Z.
    Thenappan, Thenappan
    Prins, Kurt W.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2020, 5 (12): : 1244 - 1260
  • [2] Treatment of right ventricular dysfunction in pulmonary arterial hypertension: Theoretical considerations
    Engel, Peter J.
    Baughman, Robert P.
    MEDICAL HYPOTHESES, 2009, 73 (03) : 448 - 452
  • [3] Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension
    Inampudi, Chakradhari
    Tedford, Ryan J.
    Hemnes, Anna R.
    Hansmann, Georg
    Bogaard, Harm-Jan
    Koestenberger, Martin
    Lang, Irene Marthe
    Brittain, Evan L.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (05) : 1659 - 1674
  • [4] Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Caputo, Annalisa
    Papa, Silvia
    Manzi, Giovanna
    Laviola, Domenico
    Recchioni, Tommaso
    Severino, Paolo
    Lavalle, Carlo
    Maestrini, Viviana
    Mancone, Massimo
    Badagliacca, Roberto
    Vizza, Carmine Dario
    CURRENT HEART FAILURE REPORTS, 2023, 20 (04) : 263 - 270
  • [5] Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
    Annalisa Caputo
    Silvia Papa
    Giovanna Manzi
    Domenico Laviola
    Tommaso Recchioni
    Paolo Severino
    Carlo Lavalle
    Viviana Maestrini
    Massimo Mancone
    Roberto Badagliacca
    Carmine Dario Vizza
    Current Heart Failure Reports, 2023, 20 : 263 - 270
  • [6] Urocortin-2 treatment reduces right ventricular dysfunction in pulmonary arterial hypertension
    Adao, R.
    Mendes-Ferreira, P.
    Maia-Rocha, C.
    Santos-Ribeiro, D.
    Potus, F.
    Breuils-Bonnet, S.
    Provencher, S.
    Bonnet, S.
    Rademaker, M. T.
    Leite-Moreira, A. F.
    Bras-Silva, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1103 - 1103
  • [7] Neuregulin-1 treatment reduces right ventricular dysfunction in pulmonary arterial hypertension
    Mendes-Ferreira, P.
    Adao, R.
    Maia-Rocha, C.
    Lourenco, A. P.
    Meireles, A.
    Falcao-Pires, I.
    De Keulenaer, G. W.
    Leite-Moreira, A. F.
    Bras-Silva, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S62 - S62
  • [8] The Progression Of Right Ventricular Dysfunction In Scleroderma Pulmonary Arterial Hypertension Vs. Idiopathic Pulmonary Arterial Hypertension
    Argula, R. G.
    Karwa, A.
    Lauer, A.
    Ramakrishnan, V.
    Feghali-Bostwick, C.
    Smith, E. A.
    Usher, B. W.
    Schnapp, L. M.
    Silver, R. M.
    Gregg, D.
    Strange, C. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] Right ventricular dysfunction in pulmonary hypertension
    Song, Ze-Zhou
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (02) : 232 - 232
  • [10] Epicardial Adipose Tissue Dysfunction in Pulmonary Arterial Hypertension: Implications for Right Ventricular Dysfunction
    Lemay, Sarah-Eve
    Mougin, Manon
    Martineau, Sandra
    Bonnet, Sandra Breuil
    Sauvaget, Melanie
    Boucherat, Olivier
    Provencher, Steve
    Bonnet, Sebastien
    Potus, Francois
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345